Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

NKTR 0165

Next Previous
Drug Profile

NKTR 0165

Alternative Names: Anti-tumour necrosis factor agonistic antibody; NKTR-0165; TNFR-antibody

Latest Information Update: 22 Feb 2026

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Biolojic Design; Nektar Therapeutics
  • Developer Biolojic Design; Nektar Therapeutics; University of California at San Francisco
  • Class Anti-inflammatories; Monoclonal antibodies
  • Mechanism of Action Type II tumour necrosis factor receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Autoimmune disorders; Inflammation
  • Research Multiple sclerosis

Most Recent Events

  • 17 Feb 2026 Nektar Therapeutics enters into R&D agreement with University of California, San Francisco (UCSF) for NKTR 0165 for multiple sclerosis in US
  • 17 Feb 2026 Early research in Multiple sclerosis in USA (Parenteral)
  • 07 Aug 2025 Nektar Therapeutics plans a clinical trial for unknown indication in 2026

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top